이브오진 (EVGN) 주가

이브오진(EVGN)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.49 (-2.98%), 시가총액 $0.01B, 52주 최저~최고 $0.70 ~ $2.26.

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-

핵심 지표

• 현재가: $0.49 (-2.98%)
• 시가총액: $0.01B
• 52주 최저~최고: $0.70 ~ $2.26
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NASDAQ

이브오진의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

이브오진 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 6.18
• 순이익률: -2.20%
• 영업이익률: -15.82%

자주 묻는 질문